Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Metformin Granules vs Glucophage Tablets
NCT02217670Phase 1Withdrawn
- Sponsor
- Disphar
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Disphar. Primary endpoints: Area Under the Curve from time 0 to last measurable concentration and Maximum Plasma Concentration. Status: withdrawn.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02217670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217670.